Study identification

EU PAS number

EUPAS7690

Study ID

15252

Official title and acronym

The effect of flutiform® treatment on asthma control in patients with asthma in daily clinical practice; an observational study

DARWIN EU® study

No

Study countries

Belgium

Study description

To evaluate the effect of flutiform® treatment with respect to asthma control in patients with asthma in daily clinical practice.

Study status

Ongoing
Research institutions and networks

Institutions

Hôpital Erasme
First published:
01/02/2024
Institution

Contact details

Alain Michils

Primary lead investigator

Study timelines

Date when funding contract was signed

Actual:

Study start date

Actual:

Date of final study report

Planned:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

Mundipharma Comm VA
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable